Location: Tarrytown, NY
CIK: 0000872589 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 7, 2026
Total Value: $177M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PBLS | Parabilis Medicines, Inc. | 4,166,666 | $114M | 64.4% | $27.37 | — | Common Stock | 698955101 |
| ACET | Adicet Bio, Inc. | 60,511 | $523K | 0.3% | $8.64 | — | Common Stock | 007002207 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Adicet Bio, Inc. | 60,511 | $412K | 0.2% | $0.96 | — | — | 007002108 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | 3,702,995 | $62.65M | 35.4% | $15.61 | — | Common Stock | 45826J105 |